Foresite Capital Opportunity Management V, LLC Compass Therapeutics, Inc. Transaction History
Foresite Capital Opportunity Management V, LLC
- $33.3 Million
- Q3 2022
A detailed history of Foresite Capital Opportunity Management V, LLC transactions in Compass Therapeutics, Inc. stock. As of the latest transaction made, Foresite Capital Opportunity Management V, LLC holds 1,554,250 shares of CMPX stock, worth $7.58 Million. This represents 10.64% of its overall portfolio holdings.
Number of Shares
1,554,250
Previous 1,554,250
-0.0%
Holding current value
$7.58 Million
Previous $4.12 Million
13.96%
% of portfolio
10.64%
Previous 10.38%
Shares
2 transactions
Others Institutions Holding CMPX
# of Institutions
128Shares Held
143MCall Options Held
1.02MPut Options Held
0-
Tang Capital Management LLC San Diego, CA16.8MShares$82 Million2.87% of portfolio
-
Orbimed Advisors LLC San Diego, CA15.2MShares$74.3 Million1.95% of portfolio
-
Suvretta Capital Management, LLC New York, NY14.1MShares$68.8 Million1.59% of portfolio
-
Blackstone Inc New York, NY9.84MShares$48 Million0.17% of portfolio
-
Vivo Capital, LLC Palo Alto, CA9.55MShares$46.6 Million5.69% of portfolio
About Compass Therapeutics, Inc.
- Ticker CMPX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 101,285,000
- Market Cap $494M
- Description
- Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascula...